Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Natural Products is Scopus-indexed (Q1, CiteScore 4.4), DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 2813-2602Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 10 / 57 | 83rd | Q1 |
| Plant Science | 150 / 541 | 72nd | Q2 |
| Chemistry (miscellaneous) | 75 / 137 | 45th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q1, CiteScore 4.4.
Frontiers in Natural Products is Q1 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 10 of 57), Q2 in Plant Science (rank 150 of 541) and Q3 in Chemistry (miscellaneous) (rank 75 of 137), by CiteScore 2025.
Frontiers in Natural Products is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 4.4, quartile Q1, 83rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.631, quartile Q2, with an H-index of 10.
The publisher lists an article processing charge of about US$2,353 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Natural Products is published by Frontiers Media SA. Its ISSN is 2813-2602.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Natural Products has an h-index of 14 and a 2-year mean of 4.77 citations per paper (OpenAlex). Its Scopus CiteScore is 4.4, quartile Q1. On 2-year citations it ranks #9 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Frontiers in Natural Products published 21 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2022–2026), authors are most often from Brazil (36.6%), India (6.7%) and United States (4.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.